Our analysis suggests that the combination of Plk1 and one of the following proteins: Cdc25, PP2A, APC/C inhibitors, can be potentially used to induce the cell cycle arrest and apoptosis of p53-null cancer cell lines. Here, PLK1 is linked to cancer.